These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 21247487)
1. Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival. Rubert J; Qian Z; Andraos R; Guthy DA; Radimerski T BMC Cancer; 2011 Jan; 11():24. PubMed ID: 21247487 [TBL] [Abstract][Full Text] [Related]
2. c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1. Campone M; Noël B; Couriaud C; Grau M; Guillemin Y; Gautier F; Gouraud W; Charbonnel C; Campion L; Jézéquel P; Braun F; Barré B; Coqueret O; Barillé-Nion S; Juin P Mol Cancer; 2011 Sep; 10():110. PubMed ID: 21899728 [TBL] [Abstract][Full Text] [Related]
3. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. Han J; Goldstein LA; Gastman BR; Rabinowich H J Biol Chem; 2006 Apr; 281(15):10153-63. PubMed ID: 16478725 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor. Kawabata T; Tanimura S; Asai K; Kawasaki R; Matsumaru Y; Kohno M J Biol Chem; 2012 Mar; 287(13):10289-10300. PubMed ID: 22270368 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells. Will B; Siddiqi T; Jordà MA; Shimamura T; Luptakova K; Staber PB; Costa DB; Steidl U; Tenen DG; Kobayashi S Blood; 2010 Apr; 115(14):2901-9. PubMed ID: 20160166 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Eichhorn JM; Alford SE; Sakurikar N; Chambers TC Exp Cell Res; 2014 Apr; 322(2):415-24. PubMed ID: 24556425 [TBL] [Abstract][Full Text] [Related]
8. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner. Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306 [TBL] [Abstract][Full Text] [Related]
9. Prevention of cytokine withdrawal-induced apoptosis by Mcl-1 requires interaction between Mcl-1 and Bim. Jamil S; Wang SW; Bondy L; Mojtabavi S; Duronio V Biochem Cell Biol; 2010 Oct; 88(5):809-18. PubMed ID: 20921992 [TBL] [Abstract][Full Text] [Related]
11. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer. Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa. Inoue S; Riley J; Gant TW; Dyer MJ; Cohen GM Leukemia; 2007 Aug; 21(8):1773-82. PubMed ID: 17525724 [TBL] [Abstract][Full Text] [Related]
13. IL-15 regulates Bcl-2 family members Bim and Mcl-1 through JAK/STAT and PI3K/AKT pathways in T cells. Shenoy AR; Kirschnek S; Häcker G Eur J Immunol; 2014 Aug; 44(8):2500-7. PubMed ID: 24825007 [TBL] [Abstract][Full Text] [Related]
14. Trichonomas vaginalis metalloproteinase induces apoptosis of SiHa cells through disrupting the Mcl-1/Bim and Bcl-xL/Bim complexes. Quan JH; Kang BH; Cha GH; Zhou W; Koh YB; Yang JB; Yoo HJ; Lee MA; Ryu JS; Noh HT; Kwon J; Lee YH PLoS One; 2014; 9(10):e110659. PubMed ID: 25343522 [TBL] [Abstract][Full Text] [Related]
15. The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation. Manshouri T; Quintás-Cardama A; Nussenzveig RH; Gaikwad A; Estrov Z; Prchal J; Cortes JE; Kantarjian HM; Verstovsek S Cancer Sci; 2008 Jun; 99(6):1265-73. PubMed ID: 18482053 [TBL] [Abstract][Full Text] [Related]
16. PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced. Jebahi A; Villedieu M; Pétigny-Lechartier C; Brotin E; Louis MH; Abeilard E; Giffard F; Guercio M; Briand M; Gauduchon P; Lheureux S; Poulain L Cancer Lett; 2014 Jun; 348(1-2):38-49. PubMed ID: 24650799 [TBL] [Abstract][Full Text] [Related]
18. Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells. López-Royuela N; Balsas P; Galán-Malo P; Anel A; Marzo I; Naval J Biochim Biophys Acta; 2010 Feb; 1803(2):311-22. PubMed ID: 19914305 [TBL] [Abstract][Full Text] [Related]
19. Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2. Gozgit JM; Bebernitz G; Patil P; Ye M; Parmentier J; Wu J; Su N; Wang T; Ioannidis S; Davies A; Huszar D; Zinda M J Biol Chem; 2008 Nov; 283(47):32334-43. PubMed ID: 18775810 [TBL] [Abstract][Full Text] [Related]
20. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells. Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]